Neurocrine Biosciences NBIX is set to give its latest quarterly earnings report on Friday, 2022-02-11. Here's what investors need to know before the announcement.
Analysts estimate that Neurocrine Biosciences will likely report an Earnings Per Share (EPS) of $0.52.
Neurocrine Biosciences bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Past Earnings Performance
Last quarter the company beat EPS by $0.04, which was followed by a 10.02% drop in the share price the next day.
Here's a look at Neurocrine Biosciences's past performance and the resulting price change:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.60 | 0.49 | 0.51 | 0.54 |
| EPS Actual | 0.64 | 0.63 | 0.49 | 0.91 |
| Price Change % | -10.02% | -4.61% | -2.37% | 1.39% |
Stock Performance
Shares of Neurocrine Biosciences were trading at $81.1 as of February 09. Over the last 52-week period, shares are down 30.41%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
If you want to track all upcoming earnings announcements, check out our Earnings Calendar here
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
